Mavacamten improves obstruction in adolescents with hypertrophic cardiomyopathy

Adolescent patients with obstructive hypertrophic cardiomyopathy (HCM) who received the drug mavacamten saw a significant improvement in left ventricular outflow tract (LVOT) gradient, a measure of blood flow obstruction in the heart, compared…

Continue Reading

News Source: medicalxpress.com